About Naslund Medical
Naslund Medical AB is a privately held medical products company focused on the improved management and care of patients receiving radiation therapy. As the pioneer and leader in developing new technology for fiducial markers, Naslund Medical AB markets Gold Anchor worldwide. Gold Anchor enables quicker and more effective radiation therapy treatment with increased patient safety. Naslund Medical AB is based in Sweden with a subsidiary in the U.S. and contracted distributors on a global level.
Owner and inventor
Ingemar Naslund, M.D, Ph.D. Associate professor in Oncology
The Gold Anchor has been invented and developed by Ingemar Naslund, M.D, Associate Professor, working as head of the Division of Radiation Theraphy, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden for 20 years, where he was one of the inventors of the SBRT technique in 1991 together with Ingmar Lax and Henric Blomgren.
Quality Management System
Naslund Medical AB is certified to SS-EN ISO 13485:2016 and according to the Directive 93/42/EEC on Medical Devices, Annex II, Full Quality Assurance System.
Naslund Medical has been awarded 2019 year’s Swecare Export Award for its innovation power, strategy and strong exports. We are grateful, proud and happy to be part of improving cancer care throughout the world.
Partnership with academia & healthcare
Swedish Testbed for Innovative Radiotherapy
Naslund Medical is one of the partners in a consortium aiming at establishing a Swedish testbed for innovative radiotherapy. The testbed will allow healthcare and industry to test new technology and new methods in clinical settings – and jointly drive the development of cancer treatment with radiation therapy. Learn more >
Since all cancer treatment have adverse effects on the patient, we have to do it right the first time for every individual patient, this increases the chance of cure without harming the patient – “Gentle therapy”.
Naslund Medical is one of the business partners in a consortium consisting of all teaching hospitals associated with academia and 7 important industrial companies. The long-term goal is to create a large-scale national world class platform for cancer treatment. Learn more >
Subscribe to our newsletter
Do you want to keep updated about Gold Anchor? Product development, exhibitions, testimonials. Sign up for our newsletter.